Product Code: 24268
KEY FINDINGS
The accumulation of changes in a human being over time, such as physical, psychological, and social changes are generically termed under aging. The biochemical reactions occurring within the system can be responsible for the accumulation of the changes throughout the years.
The global anti-aging market generated a revenue of $XX billion in 2018 and is projected to reach $ 344.89 billion by 2027, at a CAGR of 7.87%. The base year considered for the market study is 2018 and the forecasted period is between 2019 and 2027.
MARKET INSIGHTS
The market is expected to pick up gradual prominence in the forecasting years primarily due to the rising geriatric population that undergoes from several skin-related complications such as wrinkles, age spots, dry skin and itching, bruises, facial movement lines, infections, etc. over the years.
The Anti-wrinkles accounted for the largest share in products segment with 40.39% market share in 2018. Adoption of anti-wrinkle products for defying aging effect and increasing investment in the segment is expected to drive the adoption of anti-wrinkles products and services.
REGIONAL INSIGHTS
Geographically, the global anti-aging market has been segmented on the basis of four major regions, which are North America, Asia Pacific, Europe and the Rest of World.
The dominance of North America region on the global market is attributed to the fact of the presence of the majority of the key players that are offering their services and products in the region.
COMPETITIVE INSIGHTS
L'oreal S.A., Syneron Candela, Lutronic Corporation, Allergan Australia PTY Ltd., Personal Microderm, Alma Laser Inc. (acquired by Fosun Pharma), Avon Products, Inc., Coty Inc., Solta Medical (Valeant Pharmaceuticals), Lumenis Ltd. (acquired by Xio), Revlon, Cynosure (acquired by Hologic), Photomedex, Inc. (acquired by Radiancy, Inc.), Olay (acquired by Procter & Gamble) and Beiersdorf (acquired by Tchibo Holding AG) are the major companies operating in the global market. Most of the mentioned companies employ strategies such as that of mergers & acquisitions, partnerships, contracts, agreements, & new product launches, to gain a competitive edge over their counterpart companies.
Table of Contents
1. RESEARCH SCOPE
- 1.1. STUDY GOALS
- 1.2. SCOPE OF THE MARKET STUDY
- 1.3. WHO WILL FIND THIS REPORT USEFUL?
- 1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
- 2.1. SOURCES OF DATA
- 2.1.1. SECONDARY DATA
- 2.1.2. PRIMARY DATA
- 2.2. TOP-DOWN APPROACH
- 2.3. BOTTOM-UP APPROACH
- 2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
- 3.1. MARKET SUMMARY
- 3.2. KEY FINDINGS
- 3.2.1. GROWING NUMBER OF START-UPS IN ANTI-AGING MARKET
- 3.2.2. BABY BOOMERS-LARGEST DEMOGRAPHICS SEGMENT
- 3.2.3. GENERATION X MARKET IS PROJECTED TO GROW AT HIGHEST PACE
- 3.2.4. INCREASING NUMBER OF HAIR RESTORATION PROCEDURES TO CREATE AFFLUENT MARKET OPPORTUNITY
- 3.2.5. AESTHETIC LASER DEVICES TO GROW THE FASTEST
4. MARKET DYNAMICS
- 4.1. TIMELINE OF ANTI-AGING
- 4.2. PARENT MARKET ANALYSIS: BEAUTY & PERSONAL CARE MARKET
- 4.3. MARKET SCOPE & DEFINITION
- 4.4. MARKET DRIVERS
- 4.4.1. GROWTH IN THE NUMBER & PROPORTION OF OLDER POPULATION
- 4.4.2. RISING HOUSEHOLD DISPOSABLE INCOME PER CAPITA
- 4.4.3. SURGING PREVALENCE OF OBESITY
- 4.4.4. AWARENESS AMONG MAJORITY OF POPULATION TOWARDS SKIN HEALTH
- 4.5. MARKET RESTRAINTS
- 4.5.1. SIDE-EFFECTS OF ANTI-AGING PRODUCTS
- 4.5.2. STRICT REGULATIONS ACROSS THE GLOBE REGARDING COSMETICS
- 4.6. MARKET OPPORTUNITIES
- 4.6.1. INCREASING AWARENESS OF ANTI-AGING PRODUCTS
- 4.6.2. TECHNOLOGICAL ADVANCEMENTS IN ANTI-AGING SERVICES
- 4.7. MARKET CHALLENGES
- 4.7.1. SHIFT TOWARDS NATURAL & ORGANIC SKIN PRODUCTS
- 4.7.2. GROWING INTEREST TOWARDS THE HOME REMEDIES
5. MARKET BY DEMOGRAPHICS
- 5.1. BABY BOOMERS
- 5.2. GENERATION X
- 5.3. GENERATION Y
6. MARKET BY PRODUCT
- 6.1. UV ABSORBERS
- 6.2. ANTI-WRINKLE
- 6.3. ANTI-STRETCH MARKS
- 6.4. HAIR COLOR
7. MARKET BY DEVICES
- 7.1. ANTI-CELLULITE TREATMENT DEVICES
- 7.2. MICRODERMABRASION DEVICES
- 7.3. AESTHETIC LASER DEVICES
- 7.4. RADIOFREQUENCY DEVICES
8. MARKET BY SERVICES
- 8.1. ANTI-PIGMENTATION THERAPY
- 8.2. ADULT ACNE THERAPY
- 8.3. BREAST AUGMENTATION
- 8.4. LIPOSUCTION SERVICES
- 8.5. ABDOMINOPLASTY
- 8.6. CHEMICAL PEEL
- 8.7. EYE-LID SURGERY
- 8.8. HAIR RESTORATION
- 8.9. SCLEROTHERAPY
- 8.10. OTHER SERVICES
9. KEY ANALYTICS
- 9.1. PORTER'S FIVE FORCE MODEL
- 9.1.1. THREAT OF NEW ENTRANTS
- 9.1.2. THREAT OF SUBSTITUTE
- 9.1.3. BARGAINING POWER OF SUPPLIERS
- 9.1.4. BARGAINING POWER OF BUYERS
- 9.1.5. THREAT OF COMPETITIVE RIVALRY
- 9.2. KEY BUYING CRITERIA
- 9.2.1. COST
- 9.2.2. FORMULATION
- 9.2.3. BRAND VALUE
- 9.2.4. PRODUCT REVIEWS
- 9.3. OPPORTUNITY MATRIX
- 9.4. VENDOR LANDSCAPE
- 9.5. VALUE CHAIN ANALYSIS
- 9.5.1. SUPPLIERS
- 9.5.2. RESEARCH & DEVELOPMENT
- 9.5.3. MANUFACTURING/PRODUCTION
- 9.5.4. DISTRIBUTION & MARKETING
- 9.5.5. END-USERS
- 9.6. LEGAL, POLICY & REGULATORY FRAMEWORK
- 9.7. INVESTMENT ANALYSIS
- 9.7.1. BY REGION
- 9.7.2. BY PRODUCTS
- 9.7.3. BY DEVICES
10. GEOGRAPHICAL ANALYSIS
- 10.1. NORTH AMERICA
- 10.1.1. UNITED STATES
- 10.1.2. CANADA
- 10.2. EUROPE
- 10.2.1. UNITED KINGDOM
- 10.2.2. GERMANY
- 10.2.3. FRANCE
- 10.2.4. SPAIN
- 10.2.5. ITALY
- 10.2.6. RUSSIA
- 10.2.7. REST OF EUROPE
- 10.3. ASIA PACIFIC
- 10.3.1. CHINA
- 10.3.2. JAPAN
- 10.3.3. INDIA
- 10.3.4. SOUTH KOREA
- 10.3.5. AUSTRALIA
- 10.3.6. REST OF ASIA PACIFIC
- 10.4. REST OF WORLD
- 10.4.1. LATIN AMERICA
- 10.4.2. MIDDLE EAST & AFRICA
11. COMPETITIVE LANDSCAPE
- 11.1. MARKET SHARE ANALYSIS
- 11.2. KEY COMPANY ANALYSIS
- 11.3. CORPORATE STRATEGIES
- 11.3.1. PRODUCT LAUNCH & INNOVATION
- 11.3.2. MERGER & ACQUISITION
- 11.3.3. COLLABORATION, JOINT VENTURE & PARTNERSHIP
- 11.3.4. OTHER CORPORATE STRATEGIES
- 11.4. COMPANY PROFILES
- 11.4.1. ALLERGAN AUSTRALIA PTY LTD.
- 11.4.2. ALMA LASER INC. (ACQUIRED BY FOSUN PHARMA)
- 11.4.3. AVON PRODUCTS, INC.
- 11.4.4. BEIERSDORF (ACQUIRED BY TCHIBO HOLDING AG)
- 11.4.5. COTY INC.
- 11.4.6. CYNOSURE (ACQUIRED BY HOLOGIC)
- 11.4.7. L'OREAL S.A.
- 11.4.8. LUMENIS LTD. (ACQUIRED BY XIO)
- 11.4.9. LUTRONIC CORPORATION
- 11.4.10. OLAY (ACQUIRED BY PROCTER & GAMBLE)
- 11.4.11. PERSONAL MICRODERM
- 11.4.12. PHOTOMEDEX, INC. (ACQUIRED BY RADIANCY, INC.)
- 11.4.13. REVLON
- 11.4.14. SOLTA MEDICAL (VALEANT PHARMACEUTICALS)
- 11.4.15. SYNERON CANDELA